DECA 13G

Company

Semnur Pharmaceuticals, Inc.

Filed

February 7, 2023

Accession Number

0001393825-23-000050

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →